Enochian Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Enochian Biosciences generated cash of -$10,971,430, which is more than the previous year. Cash used in financing activities reached the amount of $10,517,455 last year. Net change in cash is therefore -$1,654,013.
Cash Flow
| 2011 | -20.15K | -13.21K | 33.5K |
|---|---|---|---|
| 2012 | -24.94K | -13.21K | 38.5K |
| 2013 | -30.09K | 0 | 36.5K |
| 2016 | -1.47M | 0 | 0 |
| 2018 | -4.33M | -575.73K | 16.71M |
| 2020 | -10.45M | -184.46K | 7.2M |
| 2023 | -11.77M | -29.77K | 4.51M |
| 2024 | -10.97M | -1.26M | 10.51M |
ENOB Cash Flow Statement (2011 – 2023)
| 2023 | 2022 | 2019 | 2017 | 2015 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.87M | 9.17M | 12.28M | 3.94M | 1.49M | 336 | 0 | 0 |
Operating activities | ||||||||
Net income | -80.65M | -39.68M | -11.41M | -6.31M | -1.73M | -37.58K | -29.94K | -34.26K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 121.85K | 113.49K | 366.26K | 18.48K | 27.39K | 0 | 0 | 0 |
Stock-based compensation expense | 4.67M | 3.53M | 1.02M | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 4.67M | 3.53M | 1.02M | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 46 | 18.81K | 108.00K | -263.29K | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 4.05M | 3.89M | 59.31K | 119.57K | 574.97K | 0 | 0 | 376 |
Cash generated by operating activities | -10.97M | -11.77M | -10.45M | -4.33M | -1.47M | -30.09K | -24.94K | -20.15K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -70.43K | -29.77K | -184.46K | -30K | 0 | 0 | 0 | 0 |
Acquisitions Net | 65.85K | 0 | 0 | -294.93K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.26M | -29.77K | -184.46K | -575.73K | 0 | 0 | -13.21K | -13.21K |
Financing activities | ||||||||
Common Stock Issued | 3M | 4.01M | 1M | 16.71M | 0 | 0 | 25K | 25K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 7.17M | -1.12M | 6.2M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 10.51M | 4.51M | 7.2M | 16.71M | 0 | 36.5K | 38.5K | 33.5K |
Net Change In Cash | -1.65M | -7.29M | -3.58M | 11.65M | -1.47M | 6.40K | 38.5K | 0 |
Cash at end of period | 220.46K | 1.87M | 8.69M | 15.60M | 23.36K | 6.74K | 336 | 123 |
| Data source | Data source | Data source |